RABEP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.214000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.274200E-01
Normal-vs-Stage2
6.276100E-02
Normal-vs-Stage3
2.080400E-01
Normal-vs-Stage4
3.200600E-01
Stage1-vs-Stage2
3.738600E-01
Stage1-vs-Stage3
1.492960E-01
Stage1-vs-Stage4
6.818400E-01
Stage2-vs-Stage3
2.880600E-01
Stage2-vs-Stage4
8.598000E-01
Stage3-vs-Stage4
2.521600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.127600E-02
Normal-vs-AfricanAmerican
5.419200E-01
Normal-vs-Asian
6.139700E-02
Caucasian-vs-AfricanAmerican
2.868200E-01
Caucasian-vs-Asian
2.957400E-01
AfricanAmerican-vs-Asian
1.282640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.324200E-02
Normal-vs-Female
1.335830E-01
Male-vs-Female
2.697400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.627400E-01
Normal-vs-Age(41-60Yrs)
1.210240E-01
Normal-vs-Age(61-80Yrs)
9.575900E-02
Normal-vs-Age(81-100Yrs)
7.920100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.706600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.657000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.366800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.225000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.837400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.613200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.989590E-02
Normal-vs-Daily Drinker
2.474600E-01
Normal-vs-Weekly Drinker
1.497160E-01
Normal-vs-Occasional Drinker
1.076200E-01
Normal-vs-Social Drinker
3.088600E-01
Non Drinker-vs-Daily Drinker
5.424800E-01
Non Drinker-vs-Weekly Drinker
3.245400E-01
Non Drinker-vs-Occasional Drinker
4.190600E-01
Non Drinker-vs-Social Drinker
1.211820E-01
Daily Drinker-vs-Weekly Drinker
1.462410E-01
Daily Drinker-vs-Occasional Drinker
1.962810E-01
Daily Drinker-vs-Social Drinker
8.848300E-02
Weekly Drinker-vs-Occasional Drinker
8.467800E-01
Weekly Drinker-vs-Social Drinker
6.259200E-01
Occasional Drinker-vs-Social Drinker
4.818400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.389200E-01
Normal-vs-Grade 2
9.939000E-01
Normal-vs-Grade 3
9.817200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.111010E-01
Grade 1-vs-Grade 3
1.442220E-01
Grade 1-vs-Grade 4
7.389200E-01
Grade 2-vs-Grade 3
8.280400E-01
Grade 2-vs-Grade 4
9.939000E-01
Grade 3-vs-Grade 4
9.817200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.793600E-02
Normal-vs-NonDiabetic
7.946300E-02
Diabetic-vs-NonDiabetic
5.715800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.592200E-02
Normal-vs-NoPancreatitis
4.991800E-02
Pancreatitis-vs-NoPancreatitis
4.409800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.702800E-01
Normal-vs-N1
6.782000E-02
N0-vs-N1
3.768000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.331720E-02
Normal-vs-TP53-NonMutant
4.917400E-01
TP53-Mutant-vs-TP53-NonMutant
1.87910000004621E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
